The view that receptor-interacting protein kinase 3 (RIPK3) expression is reported to be crucial in CRC, as its expression may affect the response to chemotherapy and, consequently, colorectal tumorigenesis and progression (Huang et al., 2023). This evidence concerns the gene RIPK3 and colorectal carcinoma.